Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 826 AL 840

CRISPR Applications in Alzheimer's Disease: From High-Throughput Genetic Screening to Precision Editing and CNS Delivery

Li Y, Ma S, Fei T.

Int J Mol Sci. 2026 Apr 9;27(8):3371. doi: 10.3390/ijms27083371.

Kynurenic acid derivatives in treatment for Alzheimer's disease

Pavilek B, Hajduová D, Bortňák D, Milata V.

Bioorg Med Chem. 2026 May;136:118601. doi: 10.1016/j.bmc.2026.118601. Epub 2026 Feb 17.

CRISPR-based correction of apolipoprotein E4 in Alzheimer's disease: Therapeutic strategies and macromolecular delivery innovations

Wang M, Niu D, Zhang Q, Tang Y, Zhao Y, Chen F.

Int J Biol Macromol. 2026 Apr;354:151352. doi: 10.1016/j.ijbiomac.2026.151352. Epub 2026 Mar 10.

Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer's Disease: A Recent Review

Kumar D, Kondaveeti SB, Agrawal M, Kumar A, Awasthi A, Mahmood S, Singh TG, Kumar M.

Mol Neurobiol. 2026 Apr 27;63(1):589. doi: 10.1007/s12035-026-05857-1.

Ginsenosides for Multi-target Intervention in Alzheimer's Disease: Current Evidence, Challenges, and Future Directions

Oriquat G, Ali AM, H M, Ahmad IA, Maharana L, Chauhan AS, Arora V, Purohit B, Kumar-Mishra M.

Mol Neurobiol. 2026 May 15;63(1):631. doi: 10.1007/s12035-026-05910-z.

Advancing Alzheimer Disease Prediction With Large Language Model-Based Linguistic Feature Analysis: Development and Validation Study

Hsu MH, Hwang SY, Tsai YH, Chang YC, Liang CK, Chang CY.

JMIR Med Inform. 2026 May 28;14:e86965. doi: 10.2196/86965.

Microglia-Astrocyte Cooperation and Peripheral T Cells in Alzheimer's Disease: State-of-the-Art and Treatment Perspectives

Bivona G, Ghersi G.

Int J Mol Sci. 2026 Apr 5;27(7):3295. doi: 10.3390/ijms27073295.

Metabolic Drivers of Alzheimer's Disease: Integrating brain Hypometabolism, insulin Resistance, and systemic dysregulation

Suswidiantoro V, Tang KS, Rahman K, Puteri MU, Wahyuni T, Ariestanti DM, James RJ, Yan CC, Kato M, Saputri FC.

Front Neuroendocrinol. 2026 Apr;81:101248. doi: 10.1016/j.yfrne.2026.101248. Epub 2026 Mar 22.

Medicinal chemistry approaches for dual inhibition of amyloid-β and tau aggregation in Alzheimer's disease

Jangra J, Mahindru I, Kumar A, Gupta HK, Ramesh VK, Kumar R.

Future Med Chem. 2026 Apr;18(8):961-978. doi: 10.1080/17568919.2026.2636501. Epub 2026 Mar 2.

Natural Products for Alzheimer's Disease: A New Twist Impacting Ferroptosis

Yi Y, Jia P, Xie P, Peng X, Zhu X, Yin S, Yan C, Yu G.

Am J Chin Med. 2026;54(3):707-731. doi: 10.1142/S0192415X26500266. Epub 2026 Apr 30.

Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease

Shen X, Dong X, Nao J.

Neuroscience. 2026 May 7;601:155-168. doi: 10.1016/j.neuroscience.2026.03.006. Epub 2026 Mar 9.

Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation

Arslan B, Gobom J, Andreasson U, Montoliu-Gaya L, Benedet AL, Dittrich A, Kern S, Skoog I, Ashton NJ, Chan T, Rahmouni N, Rosa-Neto P, Blennow K, Zetterberg H, Kvartsberg H.

Alzheimers Dement. 2026 Apr;22(4):e71374. doi: 10.1002/alz.71374.

Astrocytes and Their Role in the Development and Progression of Alzheimer's Disease: Gatekeepers of Neurodegeneration

Svobodova I, Bendova Z, Novotny J.

J Integr Neurosci. 2026 Apr 22;25(4):49765. doi: 10.31083/JIN49765.

A Systematic Review to Evaluate the Effect of Neflamapimod on Cognitive Function and Progression of Dementia

Tyagi S, Murali N, Singh SK, Babtiwale SR, Padhi BK, Lakshmi NRA, Gandhi AP.

Neurol India. 2026 Jan 1;74(1):12-19. doi: 10.4103/neurol-india.Neurol-India-D-25-00227. Epub 2026 Jan 9.

The corporate takeover of Alzheimer's treatment: a crisis in neurological autonomy?

Araujo AQC.

Arq Neuropsiquiatr. 2026 Mar;84(3):1-5. doi: 10.1055/s-0046-1817020. Epub 2026 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias